期刊文献+

顶空气相色谱法测定醋酸卡泊芬净中残留溶剂

Determination of residual solvent in caspofungin acetate by headspace gas chromatography
下载PDF
导出
摘要 建立了测定醋酸卡泊芬净原料药中甲醇、乙醇、异丙醇、乙腈、二氯甲烷、四氢呋喃和乙酸乙酯等7种残留溶剂的顶空气相色谱法,该法可以将异丙醇与乙腈峰、乙酸乙酯与四氢呋喃峰有效分离并准确定量。采用Inert Cap 624毛细管色谱柱,顶空进样,程序升温,检测器为氢火焰离子化检测器,温度为250℃,进样量为1 mL。实验结果表明:7种溶剂的线性系数均大于0.9999;各溶剂检测限为0.041~0.654μg;精密度实验的RSD均小于10%;平均回收率为95.4%~111.5%。该方法灵敏度高,准确度好,适用于醋酸卡泊芬净原料药中残留溶剂的测定。 A headspace gas chromatographic method was established for the determination of seven kinds of residual solvents in caspofungin acetate API,including methanol,ethanol,isopropanol,acetonitrile,dichloromethane,tetrahydrofuran and ethyl acetate.The peaks of isopropanol and acetonitrile,ethyl acetate and tetrahydrofuran were effectively separated and accurately quantified by this method with Inert Cap 624 capillary chromatographic column,headspace injection,programmed temperature rising,hydrogen flame ionization detector at 250℃ and injection volume 1 mL.The results showed that the linear coefficients of the seven solvents were greater than 0.9999;The detection limits of each solvent were 0.041~0.654μg;RSDs of precision test were all less than 10%;The average recoveries were 95.4%~111.5%.The method has high sensitivity and accuracy,and is suitable for the determination of residual solvents in caspofungin acetate API.
作者 张波 王秀龙 郭朝江 刘志钰 朱兵峰 张贵民 ZHANG Bo;WANG Xiulong;GUO Chaojiang;LIU Zhiyu;ZHU Bingfeng;ZHANG Guimin(Lunan Pharmaceutical Group Co.,Ltd.,Linyi 276000,China;Lunan New Time Biotechnology Co.,Ltd.,Feixian 273400,China)
出处 《发酵科技通讯》 CAS 2022年第4期202-205,235,共5页 Bulletin of Fermentation Science and Technology
关键词 醋酸卡泊芬净 顶空气相色谱法 残留溶剂 caspofungin acetate headspace gas chromatography residual solvent
  • 相关文献

参考文献6

二级参考文献89

  • 1谭湘姗,纪立伟,张弦.钠-葡萄糖共转运蛋白2抑制剂对糖尿病患者心血管系统作用的研究进展[J].中国新药杂志,2020,29(2):152-157. 被引量:13
  • 2潘毅,江必旺.纽莫康定Bo色谱纯化工艺的研究[J].生物技术世界,2012,9(7):7-8. 被引量:1
  • 3王栋海,钱秀萍,陈代杰.抗真菌药物echinocandins和pneumocandins类的研究进展[J].中国抗生素杂志,2004,29(7):439-442. 被引量:12
  • 4Arathoon EG, Gotuzzo E, Noriega LM, et al. Randomized, doubleblind, muhicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases. Antimicrob Agents Chemother, 2002, 46:451 -457.
  • 5Colombo AL, Perfect J, DiNubile M, et al. Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis. Eur J Clin Micmhinl lnf~c.t Di~ 9f~i 99./170--/17/1.
  • 6Garbino J, Lew D, Hirschel B, et al. Caspofungin in the treatment of oropharyngeal candidiasis. Int J Clin Pract, 2003, 57 : 143 - 144.
  • 7Debono M, Gordee RS. Antibiotics that inhibit fungal cell wall development. Annu Rev Microbiol, 1994, 48:471 -497.
  • 8Denning DW. Eehinocandin antifungal drugs. Lancet, 2003, 362:1142 - 1151.
  • 9Balani SK, Xu X, Arison BH, et al. Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine. Drug Metab Dispos, 2000, 28 : 1274 - 1278.
  • 10Pfaller MA, Diekema DJ, Messer SA, et al. In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp. , including 157 fluconazole-resistant isolates. Antimicrob Agents Chemother, 2003, 47:1068- 1071.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部